RILOX

This brand name is authorized in Nigeria.

Active ingredients

The drug RILOX contains one active pharmaceutical ingredient (API):

1	Ofloxacin UNII A4P49JAZ9H - OFLOXACIN
	Ofloxacin is a quinolone-carboxylic acid derivative with a wide range of antibacterial activity against both Gram-negative and Gram-positive organisms. The primary mode of action of the quinolones is the specific inhibition of bacterial DNA gyrase. This enzyme is required for DNA replication, transcription, repair and recombination.
	Read more about Ofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-4492	Film coated tablet	RILOX 400MG TABLETS TAB_FILM_COATED 400 mg 1 X 10	32 CMS-PP-391298 RILOX 400MG TABLETS OFLOXACIN USP 400MG EACH FILM COATED TABLET CONTAISN OFLOXACIN USP 400MG LACTOSE BP, MICROCRYSTALLINE CELLULOSE BP, MAIZE STARCH BP, PROVIDONE BP, ISOPRPYL ALCOHOL USP, SODIUM STARCH GLYCOLATE, MAGNESIUM STEARATE BP Apr-92 Drugs Imported Products 1X10 Prescription Only Medicine (POM) 11/22/2023 DONY-TRIUMPH AND COMPANY NIGERIA LIMITED, I/I J POND STREET,HOUSING ESTATE FEGGE ONITSHA ANAMBRA STATE 80868969 donytrump15@yahoo.com BAFNA PHARMACEUTICALS LTD, NO 147 MADHAVARAM REDHILLS HIGH RODS, GRANLYON VILLAGE, VADAKARI POST, CHENNAI-600 052. INDIA., India	28/02/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA01	Ofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-4492